Uterine papillary serous cancer

Authors

  • David G Allen University of Melbourne

Keywords:

uterine papillary serous cancer, treatment

Abstract

There is much about the management of endometrial cancer that remains controversial. The literature contains very little good evidence to guide our practice on uterine papillary serous cancer (UPSC). UPSC is an aggressive histological subtype of endometrial cancer, accounting for less than 5% of its incidence, but 40% of its mortality. UPSC has a higher propensity for lymphovascular space invasion (LVSI), and intraperitoneal as well as extra-abdominal spread, than the more common endometrioid cancers.

Author Biography

  • David G Allen, University of Melbourne
    MBChB, MMed(O&G), PhD, FCOG(SA), AFRACMA, FRANZCOG, CGO Gynaecological Oncologist Mercy Hospital for Women Melbourne Australia

Downloads

Additional Files

Issue

Vol. 7 No. 1 (2015)

Section

Guest Editorial

License

South African Journal of Gynaecological Oncology (SAJGO) Copyright is held by South African Society of Gynaecologic Oncology (SASGO). Copyright of the articles is held by the authors. The work is licensed under a Creative Commons Attribution-Non-Commercial Works 4.0 South Africa License (CC BY NC). Material submitted for publication in the SAJGO is accepted provided it has not been published elsewhere. The SAJGO does not hold itself responsible for statements made by the authors. The opinions expressed in this publication are those of the authors. They do no purport to reflect the opinions or views of SASGO or its members.